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Abstract: Carcinoembryonic antigen (CEA) is a tumor marker for detecting recurrences of adenocarci-
nomas such as colon cancer. In lung adenocarcinoma, CEA elevation can be found in both serum and
malignant pleural effusion. However, CEA elevation in cytologically negative pleural effusion in the pres-
ence of adenocarcinoma without pleural infiltration has not been described. We here present the case
of an 82-year-old man with incidental early stage adenocarcinoma of the right upper lobe showing CEA
elevation in pleural fluid and serum despite negative cytological findings. Due to limited lung reserve the
tumor was removed by wide wedge resection, but the visceral pleura was not affected and infiltration of
the parietal pleura was ruled out by pleural biopsies. Serum and pleural CEA levels declined postopera-
tively as measured at 1 and 2 months follow-up. This case shows CEA elevation in serum and pleural fluid
in early stage lung adenocarcinoma with negative cytology and no sign of pleural infiltration. Previous
research revealed that CEA level in pleural effusion correlates to serum CEA and is significantly higher
in adenocarcinoma of the lung than in other lung cancer entities. Firstly, this case suggests that deter-
mination of CEA levels can increase the diagnostic sensitivity in cases with cytologically negative pleural
effusion suspicious of malignant origin and secondly, it contributes valuable information to the decision
whether follow-up of pulmonary nodules or continuative diagnostics such as video-assisted thoracoscopic
surgery (VATS) wedge resection is indicated.
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Introduction
Carcinoembryonic antigen (CEA) is a glycoprotein involved 
in cell adhesion and is usually produced in gastrointestinal 
tissue during fetal development. Elevated CEA serum levels 
in adults are found in adenocarcinomas of various origin, 
thus qualifying CEA as a tumor marker. CEA elevation 
has been shown for pulmonary adenocarcinoma both in 
serum and malignant pleural effusion (1,2). However, 
CEA elevation in cytologically negative pleural effusion 
accompanying adenocarcinoma without pleural infiltration 
has not been shown previously.
Case presentation
We here present an 82-year-old man with an incidental lung 
adenocarcinoma of the right upper lobe, displaying elevated 
CEA levels in pleural effusion and serum. 
Initial admission was due to progressive dyspnea on 
exertion and orthopnea 7 months after trauma to the right 
hemithorax with fracture of rib No. 7 and 8. The treatment 
consisted of pain medication. 
The patient’s history revealed productive cough, 
movement-induced pain located in the right shoulder, 
former nicotine abuse until 2008 (40 packyears) and no B 
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symptoms. On examination, the patient presented thoracic 
pressure pain on the right, lowered breath sound and 
subdued resonance over the basal right lung. Confirmatory 
chest X-ray showed a unilateral pleural effusion on the 
right side (Figure 1). Initial lab test results revealed normal 
findings.
For subsequent diagnostic evaluation and therapy, 
pleural fluid was drained with a chest tube. Cytological and 
microbiological analysis showed an exudate with negative 
cytology results and no bacterial growth. 
Given the long history of 7 months after thoracic trauma, 
possible malignancy was considered. Thus, aside from 
routine diagnostic parameters, CEA and cancer antigen 
19-9 (CA 19-9) levels were determined in serum and pleural 
effusion. Surprisingly, while CA 19-9 levels in serum 
and pleural fluid was normal, CEA levels were elevated 
215-fold over threshold (reference range <4.6 µg/L) in 
pleural effusion and 30-fold in serum (Figure 2). 
Computed tomography (CT) scan of the chest and 
abdomen revealed a 15-mm pulmonary mass in segment 
1 of the right upper lobe (Figure 3). 
Due to limited lung reserve, video-assisted thoracoscopic 
surgery (VATS) wedge resection was performed instead of 
lobectomy. Besides, multiple pleural biopsies were taken 
from areas macroscopically suspicious of malignancy. 
Histopathological analysis showed a 15-mm, moderately 
differentiated acinar cell adenocarcinoma without infiltration 
of the visceral pleura (pT1b cN0 cM0 R0) (Figure 4). 
Analysis of specimens obtained from parietal pleura revealed 
low grade chronic fibrosing pleuritis with no sign of tumor 
infiltration.
CEA levels in serum were determined 2 and 3 weeks 
postoperatively as well as during follow-up after 1 and 
2 months. Serum and pleural CEA levels showed an overall 
decline of CEA concentrations up to now at 2 months 
follow-up (Figure 2).
Discussion
This case reveals a previously unencountered constellation 
of early stage pulmonary adenocarcinoma which has 
not affected visceral or parietal pleura, presenting with 
cytologically negative pleural effusion, but elevated CEA 
levels in pleural fluid and serum.
While the infiltration of the visceral pleura explains CEA 
elevation in malignant pleural effusions associated with lung 
adenocarcinoma, CEA elevation in this case with negative 
cytology and absence of pleural affection is not plausible 
and thus unexpected.
In an early stage tumor as in this case (T1b), the 
occurrence of malignant pleural effusion is not expected. 
Considering possible causes for pleural effusion in our 
case, malignant or benign, increased CEA levels in pleural 
fluid indicate malignant genesis. However, negative 
cytological testing indicates lack of circulating tumor cells 
and histopathology showed no sign of pleural infiltration as 
well as adequate safety margins after tumor removal (R0). 
Figure 1 Chest X-ray on admission showing unilateral pleural 
effusion on the right side and a solitary pulmonary nodule in the 
right upper lobe (white arrow).
Figure 2 CEA concentration in μg/L, reference range <4.6 μg/L. 
Serum and pleural CEA concentration measured preoperatively 
and for follow-up at 1 and 2 months, depicting declining CEA 
levels after tumor removal. CEA, carcinoembryonic antigen.
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Enz et al. CEA in cytologically negative pleural fluid
The patient’s history with thoracic trauma and fractured 
ribs supports the finding of a benign pleural effusion. 
Additionally, histological examination of parietal pleura 
biopsies showed fibrous, inflammatory reaction of tissue, 
but no signs or evidence of malignancy. This raises the 
question for the causes of the increase of pleural CEA 
levels in lung adenocarcinoma without pleural affection and 
cytological examination providing no evidence of tumor 
cells. One possible explanation is a CEA production by 
isolated tumor cells circulating in pleural fluid that evade 
detection in cytological analysis. Unsatisfactory sensitivity 
of cytological detection of tumor cells in malignant pleural 
effusions ranging between 30–80% (2-6) is in support of 
this hypothesis. Thus, CEA might be an additional indicator 
of tumor cells present in pleural effusion. Tozzoli et al. 
showed that pleural CEA levels determined additionally 
to cytological examination increased the sensitivity in 
diagnosing malignant pleural effusion in non-small cell 
lung cancer (NSCLC) to approximately 100% (2). Another 
possible hypothesis ist that pleural affection might not 
have yet occurred. Rather, aside from being secreted by 
tumor cells, pleural CEA could be elevated due to delayed 
degradation of CEA caused by slower metabolism in pleural 
effusion than in serum (5,7).
Review of literature revealed great heterogeneity of 
data that were included into analysis regarding cytological 
findings and tumor stages. Pleural effusions seem to be 
investigated mainly in tumors with pleural infiltration. Hsieh 
et al. investigated tumor markers in lung adenocarcinoma-
associated cytologically negative pleural effusions. These 
findings showed that mean tumor marker levels were 
significantly higher in lung adenocarcinoma-associated 
malignant (cytologically positive) pleural effusion than in 
cytologically negative pleural effusion, which could indicate 
that pleural infiltration might have not yet occurred. 
Nevertheless, positive cytology in all patients is reported 
Figure 3 Preoperative CT. (A) Chest CT lung window scanning image showing a 15-mm tumor in the right upper lobe; (B) tumor displayed 
in chest CT soft tissue window. CT, computed tomography. 
Figure 4 Histopathological image of the analyzed tumor specimen obtained from the right upper lobe by wide wedge resection (HE 
staining) showed moderately differentiated acinar cell adenocarcinoma (A: ×100; B: ×200).
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after 3 months (5). 
Moreover, few studies have been published strictly 
differentiating pleural effusion in lung adenocarcinoma from 
other histological entities of lung carcinoma. Some studies, 
however, showed that CEA levels in lung adenocarcinoma-
associated pleural effusions are significantly higher than in 
pleural effusions accompanying other histological entities 
such as small cell lung cancer (SCLC) and squamous cell 
carcinoma (1,7-9).
Comparison of serum CEA with pleural CEA levels 
yielded a positive correlation. Meanwhile, pleural CEA 
levels appeared to be significantly higher than in serum 
(1,2). According to this finding, Tozzoli et al. argue against 
the diagnostic benefit of serum CEA in comparison with 
determining pleural CEA levels (2). Opposingly, serum 
CEA level might prove valuable as a follow-up parameter 
monitoring outcome, relapse or tumor progression.
As implicated by this case report, determining levels 
of CEA in serum and pleural fluid might prove helpful in 
certain defined cases. Firstly, in suspected malignant yet 
cytologically negative pleural effusion the determination of 
pleural CEA levels leads to a higher diagnostic sensitivity. 
Secondly, in cases similar to this patient’s with incidental and 
clinically inapparent pulmonary nodules morphologically 
uncharacteristic for lung cancer, where follow-up via CT 
imaging is justified. In these cases, the determination of CEA 
levels in serum and, if present, in pleural effusion, provides a 
potential tool to rule out or confirm malignancy. This could 
be especially relevant in patients with pathologically altered 
lung parenchyma, as in chronic obstructive pulmonary 
disease (COPD), in which case distinguishing between 
malignant and benign pulmonary findings can pose a 
diagnostic challenge. Applied in relevant cases, the diagnostic 
benefit of CEA level determination highly outweighs the 
cost, especially with regard to otherwise necessary follow-
up chest CT scans, possible diagnostic VATS or even tumor 
progression between follow-up examinations.
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